If Beta-2-Glycoprotein Antibodies are ordered without further specification, only Beta -2-Glycoprotein Antibodies IgG and IgM (B2GG and B2GM) will be done.
Antiphospholipid antibodies (APA) are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.These antibodies can be IgG, IgM, or IgA.
Antiphospholipid antibodies require several different tests for detection. Lupus anticoagulants are detected by clotting methods. APA such as anticardiolipin antibody and anti-beta 2 glycoprotein 1 antibodies are detected by immunologic assays. Anti-Beta 2 Glycoprotein Antibodies are a more specific marker for increased risk of thrombosis than anticardiolipin assays. APA associated with thrombotic risk are persistent, and should be confirmed by a repeat positive test after 2-3 months. APA results aid in diagnosis and are helpful in determining the intensity and duration of anticoagulant treatment for patients with Antiphospholipid Syndrome and thrombosis.
Sample Type
Serum
Collect
Gold top preferred, Red top acceptable
Amount to Collect
3 mL blood
Preferred Volume
1 mL serum
Minimum Volume
0.5 mL serum
Unacceptable Conditions
Lipemia or gross hemolysis.
Test Code
B2GPG
Test Group
Beta-2-glycoprotein
Performing Lab
Immunology
Specimen Preparation
If Beta-2-Glycoprotein Antibodies are ordered without further specification, order both Beta -2-Glycoprotein Antibodies IgG and IgM (B2GPG and B2GPM).
Freeze serum at -20C.
Preferred Volume
1 mL serum
Minimum Volume
0.5 mL serum
Unacceptable Conditions
Lipemia or gross hemolysis.
Units
CU
Reference Interval
< 20.1 CU
Additional Information
If Beta-2-Glycoprotein Antibodies are ordered without further specification, only Beta -2-Glycoprotein Antibodies IgG and IgM (B2GG and B2GM) will be done.
Antiphospholipid antibodies (APA) are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.These antibodies can be IgG, IgM, or IgA.
Antiphospholipid antibodies require several different tests for detection. Lupus anticoagulants are detected by clotting methods. APA such as anticardiolipin antibody and anti-beta 2 glycoprotein 1 antibodies are detected by immunologic assays. Anti-Beta 2 Glycoprotein Antibodies are a more specific marker for increased risk of thrombosis than anticardiolipin assays. APA associated with thrombotic risk are persistent, and should be confirmed by a repeat positive test after 2-3 months. APA results aid in diagnosis and are helpful in determining the intensity and duration of anticoagulant treatment for patients with Antiphospholipid Syndrome and thrombosis.
CPT Codes
86146
Available Stat
No
Test Code
B2GPG
Test Group
Beta-2-glycoprotein
Performing Lab
Immunology
Performed
Thursday (day shift)
Methodology
Chemiluminescent Immunoassay
Collect
Gold top preferred, Red top acceptable
Amount to Collect
3 mL blood
Sample Type
Serum
Preferred Volume
1 mL serum
Minimum Volume
0.5 mL serum
Unacceptable Conditions
Lipemia or gross hemolysis.
Specimen Preparation
If Beta-2-Glycoprotein Antibodies are ordered without further specification, order both Beta -2-Glycoprotein Antibodies IgG and IgM (B2GPG and B2GPM).
Freeze serum at -20C.
Units
CU
Reference Interval
< 20.1 CU
Reported
Turn around time 2-8 days
Additional Information
If Beta-2-Glycoprotein Antibodies are ordered without further specification, only Beta -2-Glycoprotein Antibodies IgG and IgM (B2GG and B2GM) will be done.
Antiphospholipid antibodies (APA) are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.These antibodies can be IgG, IgM, or IgA.
Antiphospholipid antibodies require several different tests for detection. Lupus anticoagulants are detected by clotting methods. APA such as anticardiolipin antibody and anti-beta 2 glycoprotein 1 antibodies are detected by immunologic assays. Anti-Beta 2 Glycoprotein Antibodies are a more specific marker for increased risk of thrombosis than anticardiolipin assays. APA associated with thrombotic risk are persistent, and should be confirmed by a repeat positive test after 2-3 months. APA results aid in diagnosis and are helpful in determining the intensity and duration of anticoagulant treatment for patients with Antiphospholipid Syndrome and thrombosis.
CPT Codes
86146
Ordering
Available Stat
No
Performing Lab
Immunology
Performed
Thursday (day shift)
Methodology
Chemiluminescent Immunoassay
Reported
Turn around time 2-8 days
Additional Information
If Beta-2-Glycoprotein Antibodies are ordered without further specification, only Beta -2-Glycoprotein Antibodies IgG and IgM (B2GG and B2GM) will be done.
Antiphospholipid antibodies (APA) are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.These antibodies can be IgG, IgM, or IgA.
Antiphospholipid antibodies require several different tests for detection. Lupus anticoagulants are detected by clotting methods. APA such as anticardiolipin antibody and anti-beta 2 glycoprotein 1 antibodies are detected by immunologic assays. Anti-Beta 2 Glycoprotein Antibodies are a more specific marker for increased risk of thrombosis than anticardiolipin assays. APA associated with thrombotic risk are persistent, and should be confirmed by a repeat positive test after 2-3 months. APA results aid in diagnosis and are helpful in determining the intensity and duration of anticoagulant treatment for patients with Antiphospholipid Syndrome and thrombosis.
Collection
Sample Type
Serum
Collect
Gold top preferred, Red top acceptable
Amount to Collect
3 mL blood
Preferred Volume
1 mL serum
Minimum Volume
0.5 mL serum
Unacceptable Conditions
Lipemia or gross hemolysis.
Processing
Test Code
B2GPG
Test Group
Beta-2-glycoprotein
Performing Lab
Immunology
Specimen Preparation
If Beta-2-Glycoprotein Antibodies are ordered without further specification, order both Beta -2-Glycoprotein Antibodies IgG and IgM (B2GPG and B2GPM).
Freeze serum at -20C.
Preferred Volume
1 mL serum
Minimum Volume
0.5 mL serum
Unacceptable Conditions
Lipemia or gross hemolysis.
Result Interpretation
Units
CU
Reference Interval
< 20.1 CU
Additional Information
If Beta-2-Glycoprotein Antibodies are ordered without further specification, only Beta -2-Glycoprotein Antibodies IgG and IgM (B2GG and B2GM) will be done.
Antiphospholipid antibodies (APA) are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.These antibodies can be IgG, IgM, or IgA.
Antiphospholipid antibodies require several different tests for detection. Lupus anticoagulants are detected by clotting methods. APA such as anticardiolipin antibody and anti-beta 2 glycoprotein 1 antibodies are detected by immunologic assays. Anti-Beta 2 Glycoprotein Antibodies are a more specific marker for increased risk of thrombosis than anticardiolipin assays. APA associated with thrombotic risk are persistent, and should be confirmed by a repeat positive test after 2-3 months. APA results aid in diagnosis and are helpful in determining the intensity and duration of anticoagulant treatment for patients with Antiphospholipid Syndrome and thrombosis.
Administrative
CPT Codes
86146
Complete View
Available Stat
No
Test Code
B2GPG
Test Group
Beta-2-glycoprotein
Performing Lab
Immunology
Performed
Thursday (day shift)
Methodology
Chemiluminescent Immunoassay
Collect
Gold top preferred, Red top acceptable
Amount to Collect
3 mL blood
Sample Type
Serum
Preferred Volume
1 mL serum
Minimum Volume
0.5 mL serum
Unacceptable Conditions
Lipemia or gross hemolysis.
Specimen Preparation
If Beta-2-Glycoprotein Antibodies are ordered without further specification, order both Beta -2-Glycoprotein Antibodies IgG and IgM (B2GPG and B2GPM).
Freeze serum at -20C.
Units
CU
Reference Interval
< 20.1 CU
Reported
Turn around time 2-8 days
Additional Information
If Beta-2-Glycoprotein Antibodies are ordered without further specification, only Beta -2-Glycoprotein Antibodies IgG and IgM (B2GG and B2GM) will be done.
Antiphospholipid antibodies (APA) are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.These antibodies can be IgG, IgM, or IgA.
Antiphospholipid antibodies require several different tests for detection. Lupus anticoagulants are detected by clotting methods. APA such as anticardiolipin antibody and anti-beta 2 glycoprotein 1 antibodies are detected by immunologic assays. Anti-Beta 2 Glycoprotein Antibodies are a more specific marker for increased risk of thrombosis than anticardiolipin assays. APA associated with thrombotic risk are persistent, and should be confirmed by a repeat positive test after 2-3 months. APA results aid in diagnosis and are helpful in determining the intensity and duration of anticoagulant treatment for patients with Antiphospholipid Syndrome and thrombosis.
